Clygan 1.5mg Gel
Marketer
Indoco Remedies Ltd
Salt Composition
Ganciclovir (1.5mg)
Overview Clygan 1.5mg Gel
Ganciclovir 1.5mg ophthalmic gel is an antiviral medication indicated for the treatment of cytomegalovirus (CMV) infections in immunocompromised individuals post-organ or bone marrow transplant. This formulation also mitigates the risk of CMV retinitis, a sight-threatening CMV infection of the eye. Apply only to the eyes as directed by your physician. Always wash hands before and after administration. Avoid touching the applicator tip to the eye; gently squeeze the gel into the lower conjunctival sac. Mild, transient eye irritation may occur; however, this typically resolves spontaneously. Report persistent irritation to your doctor. Refrain from contact lens use during treatment.
Uses of Clygan 1.5mg Gel
CMV Infection
Major Benefits of Clygan 1.5mg Gel:
Apply this medication topically only. Administer as directed by your physician, following the prescribed dosage and treatment schedule. Consult the product label for application instructions prior to use. Keep the applicator tip near, but not touching, the eye. Carefully dispense the medication into the lower conjunctival sac.
Common Side effects of Clygan 1.5mg Gel:
- Eye irritation
How to use Clygan 1.5mg Gel:
Apply this medication topically only. Follow your physician's prescribed dosage and treatment schedule. Always consult the product label for application instructions. Keep the applicator near, but not touching, the eye. Carefully dispense the medication into the lower conjunctival sac.
How Clygan 1.5mg Gel works:
Ocuvir 1.5mg Gel is an antiviral ophthalmic agent indicated for the treatment of ocular viral infections. Its mechanism of action involves inhibiting viral replication on the corneal surface, thus halting further viral production and resolving the infection.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
Use of Clygan 1.5mg Gel during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Clygan 1.5mg Gel while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Using Clygan 1.5mg Gel might lead to adverse reactions impacting driving capabilities. These could include drowsiness, dizziness, confusion, tremors, loss of equilibrium, or seizures.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Clygan 1.5mg Gel :
Should you forget a Clygan 1.5mg Gel application, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Clygan 1.5mg Gel
| Label | Value |
|---|---|
| Chemical Category | Base analog nucleotide |
| Developing Habits | No. |
| Type of Therapy | Ophthalmology |
| Actions | Non-HIV antiviral medications |
3,018 People bought this recently